Private Prescription Access: Skip the NHS Queue
Is Wegovy or Mounjaro Better for Weight Loss: Understanding the Private Route
The fundamental difference when comparing Wegovy versus Mounjaro through private prescription lies in immediate accessibility rather than clinical superiority. While NHS patients face 6+ month waiting lists for specialist weight management services, private prescription allows you to access either treatment within days of your clinical assessment. Both medications require the same BMI criteria (≥30, or ≥27 with weight-related comorbidities), but private providers can conduct this assessment without GP referrals or secondary care bottlenecks.
When patients ask "is Wegovy or Mounjaro better for weight loss" in the private setting, the answer often depends on practical factors like storage convenience, injection frequency, and individual tolerance profiles. Wegovy offers superior travel flexibility with 6 weeks room temperature storage compared to Mounjaro's 21 days. Both are once-weekly injections, but Wegovy uses Novo Nordisk's established FlexTouch pen technology, whilst Mounjaro utilises Eli Lilly's KwikPen system.
Wegovy vs Mounjaro Pricing: Private Prescription Cost Comparison
Private prescription costs for both treatments follow structured dose escalation schedules, making direct price comparison essential for budget planning. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose (new customers use code FIRST40 at checkout), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle combines the first two doses for £169.99, providing eight weeks of initial treatment.
While Mounjaro follows a different pricing structure due to its dual GIP/GLP-1 mechanism, both treatments represent significant monthly investments that NHS provision would eliminate. However, private prescription removes the uncertainty of NHS specialist approval and provides Reliable Supply continuity. Returning customers benefit from the DOSE25 discount code, and our bundle options like the Ultimate Stability Trio (£649.99 for three months of maintenance supply) offer convenience for established patients.
Clinical Evidence: How Wegovy and Mounjaro Compare for Weight Loss Effectiveness
When evaluating "is Wegovy or Mounjaro better for weight loss" from a clinical perspective, both medications have demonstrated substantial efficacy in their respective trial programmes. Wegovy's STEP trials showed patients achieved approximately 15% average weight loss at 68 weeks alongside diet and exercise, with the STEP 5 trial confirming 15.2% sustained weight loss at two years. The recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, expanding Wegovy's clinical value beyond weight management alone.
Mounjaro's SURMOUNT trials revealed similar magnitude results, though direct head-to-head comparisons remain unavailable due to different trial designs and patient populations. Both medications require commitment to reduced-calorie diet and increased physical activity, and both carry the MHRA's Black Triangle (▼) additional monitoring status as relatively new treatments in the weight management space.
Mechanism Differences: How Wegovy Works Compared to Mounjaro
Understanding whether Wegovy or Mounjaro is better for weight loss requires grasping their distinct mechanisms of action at the cellular level. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics the natural incretin hormone responsible for post-meal satiety signalling. This mechanism reduces appetite by acting on hypothalamic appetite centres whilst slowing gastric emptying to promote feelings of fullness after smaller meal portions. Mounjaro utilises tirzepatide, a dual GIP/GLP-1 receptor agonist that activates both glucose-dependent insulinotropic polypeptide and GLP-1 pathways simultaneously. This dual action may provide enhanced glycaemic control alongside appetite suppression, though both treatments ultimately work by modulating neural appetite regulation rather than blocking nutrient absorption.
Private Prescription Process: Getting Wegovy or Mounjaro Without NHS Delays
The private prescription pathway eliminates traditional healthcare barriers that delay access to these prescription-only medicines through conventional NHS routes. EverydayMeds' 3-minute online clinical assessment captures essential medical history, current medications, and weight management goals without requiring face-to-face consultations or GP referral letters. Our prescriber review process typically completes within 3 working days (24-hour express service available), followed by next-day cold-chain delivery once treatment approval is confirmed. This streamlined approach means patients can start either Wegovy or Mounjaro within one week of initial enquiry, compared to 6+ months through NHS specialist weight management services. All medications are sourced directly from licensed UK wholesalers and dispensed by our GPhC-registered pharmacy (#9012878) with full temperature control throughout delivery.
Storage and Practical Considerations: Wegovy vs Mounjaro Daily Management
Practical management differences significantly impact patient experience when choosing between these treatments for long-term weight management. Both require refrigerated storage at 2-8°C before first use, but Wegovy provides superior travel convenience with 6 weeks room temperature tolerance (below 30°C) compared to Mounjaro's 21-day limit. Wegovy's FlexTouch pen system offers established injection mechanics familiar to diabetes patients, whilst both treatments follow mandatory dose escalation protocols to minimise gastrointestinal side effects. The weekly injection schedule for both medications provides convenience advantages over daily treatments, though patients must maintain consistent injection timing for optimal therapeutic effect. Dose escalation cannot be accelerated or skipped regardless of individual tolerance, making treatment timeline predictability important for both options.
Is Wegovy or Mounjaro Better for Weight Loss: Individual Suitability Factors
Determining individual suitability between Wegovy and Mounjaro extends beyond simple efficacy comparisons to encompass personal health profiles and lifestyle requirements. Patients with type 2 diabetes may benefit from Mounjaro's dual incretin action for enhanced glycaemic control, whilst those prioritising cardiovascular risk reduction might favour Wegovy's proven SELECT trial outcomes. Previous experience with GLP-1 treatments, family history of medullary thyroid carcinoma, and personal history of pancreatitis all influence prescriber recommendations during clinical assessment.
Geographic considerations also matter for UK patients accessing private prescription services. Wegovy's extended room temperature stability supports frequent business travel or remote living situations where refrigeration access varies. Both treatments require identical lifestyle commitments to reduced-calorie dieting and increased physical activity, making motivation and adherence capacity equally important regardless of medication choice. Your EverydayMeds prescriber evaluation considers these multifactorial elements to recommend the most appropriate option for your circumstances.
Making Your Decision: Both Wegovy and Mounjaro Available Through EverydayMeds
Rather than definitively answering "is Wegovy or Mounjaro better for weight loss," the optimal choice depends on your individual medical history, lifestyle requirements, and treatment preferences assessed during clinical consultation. Both treatments are available through EverydayMeds with identical convenience benefits: no GP referral requirements, rapid prescriber review, and next-day delivery once approved. Our clinical team provides personalised recommendations based on your assessment responses, ensuring you receive the most suitable treatment for your weight management goals. New customers can access either option using code FIRST40 at checkout, with returning patients benefiting from DOSE25 savings on subsequent orders. Start your private prescription journey today by visiting https://everydaymeds.co.uk/collections/wegovy and complete your 3-minute clinical assessment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
